HAE

HAE Operating Income Growth

13.74%TTM

Period ending:

HAE TTM Operating Income YoY %%
HAE TTM Operating Income YoY %1056.72%-357.89%
1992-03-312026-06-27

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

HAE operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 138 observations from Mar 31, 1992 to Jun 27, 2026.

Haemonetics Corp Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
13.7377%
19.9123%
34.2247%
38.399%
43.1064%
22.4784%
6.0108%
-0.0728%
-15.6183%
5.6719%
21.5878%
26.5563%
62.4715%
93.2297%
246.6837%
193.1318%
38.6606%
-10.0248%
-70.5132%
-67.1424%
-38.1294%
-13.1629%
35.3053%
55.0687%
97.6413%
23.707%
36.8233%
89.9243%
44.8516%
48.7704%
573.3999%
919.8251%
777.3039%
389.7529%
-147.9632%
109.1842%
109.2208%
55.8941%
221.3041%
-194.734%
-220.995%
-208.3944%
-164.48%
27.4832%
-12.357%
-14.3446%
-20.5058%
-17.9605%
42.239%
-16.1371%
-12.2254%
-27.4115%
-52.8437%
-36.4163%
-38.271%
-30.6871%
-29.3279%
-19.7118%
12.7603%
20.3575%
35.8905%
32.7394%
-11.8868%
-13.4912%
-12.3336%
-2.6704%
10.9277%
15.8589%
25.3453%
21.736%
15.916%
13.331%
16.0467%
11.7525%
-13.396%
-14.3538%
-33.4146%
-36.4792%
35.2817%
31.4101%
50.5545%
65.1869%
9.7482%
12.6366%
20.5553%
30.6602%
57.6928%
64.4881%
46.3681%
22.4072%
-12.1635%
4.6983%
-1.7346%
-30.1898%
50.1307%
-8.191%
14.8955%
300.1118%
-22.8215%
5.3685%

Compare operating income growth

All HAE financial metrics · HAE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.